Keyphrases
Soluble Fas
100%
Amniotic Fluid
72%
Fetus
72%
Catechol-O-methyltransferase
64%
Intra-amniotic Infection
64%
Apoptosis
64%
Human Fetal Membranes
64%
Preterm Infants
64%
Cerebral Palsy
64%
Pregnant Women
60%
During Pregnancy
53%
Gestational Age
53%
Fas Ligand
48%
Preeclampsia
44%
Seizure
44%
Preterm Labor
42%
Perinatal Outcome
41%
Preterm Birth
40%
Prenatal Diagnosis
40%
Hemoglobin
38%
Magnesium Sulfate
38%
Neonatal Period
36%
Pregnant Rats
35%
Neonatal Outcome
35%
Fetal Origins
32%
Interleukin-6
32%
Water Disinfectant
32%
Fetal Brain
32%
Smooth muscle Tumor
32%
African Women
32%
Intraplacental
32%
Human Amnion
32%
Chloroacetonitrile
32%
Twin Pregnancy
32%
Matrix metalloproteinase-9 (MMP-9)
32%
Wolf-Hirschhorn Syndrome
32%
Overlapping Features
32%
Cervical Resistance
32%
Methyltransferase Activity
32%
Pregnancy Cohort
32%
Maternal-fetal Medicine
32%
Patient-centered
32%
Low-risk Pregnancy
32%
Single Umbilical Artery
32%
COVID-19 Patients
32%
Oxidative Stress
32%
Tocolysis
32%
COVID-19
32%
Ligand System
32%
Magnesium
32%
Medicine and Dentistry
Pregnancy
95%
Premature Labor
85%
Amnionitis
64%
Amnion Fluid
64%
Methyltransferase
64%
Spastic Diplegia
64%
Gestational Age
62%
Cesarean Section
52%
Amnion
46%
Epileptic Seizure
42%
Pre-Eclampsia
42%
High Risk Pregnancy
40%
Prenatal Diagnosis
40%
Newborn Period
37%
Programmed Cell Death
36%
Interleukin 6
32%
COVID-19
32%
Twin Pregnancy
32%
Peak Expiratory Flow
32%
Monoamniotic Twins
32%
Single Umbilical Artery
32%
Gelatinase B
32%
Prostaglandin E2
32%
Wolf-Hirschhorn Syndrome
32%
Incision
32%
Hematocrit
32%
Tocolysis
32%
Diabetic Ketoacidosis
32%
Elevated Transaminases
32%
Fetal Membrane
32%
Indometacin
32%
Hemoglobins
32%
Severe Acute Respiratory Syndrome Coronavirus 2
32%
Platelet
32%
Race Difference
32%
Angioleiomyoma
32%
Perinatology
32%
Systemic Lupus Erythematosus
32%
Placenta
32%
Magnesium
32%
Hypersensitivity Angiitis
32%
P16
32%
Brain Death
32%
Infection
27%
Methyltransferase Inhibitor
27%
Protein Methyltransferase
24%
Medicine
24%
Mifepristone
24%
Obstetrics
24%
Fas Ligand
21%